Cargando…
Preliminary validation of nCounter PanCancer immune profiling of FFPE slides and pbmc in CITN-05, a CITN study of the immunological effects of an IDO1 inhibitor in patients with ovarian carcinoma
| Autores principales: | , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2015
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4646049/ http://dx.doi.org/10.1186/2051-1426-3-S2-P84 |
| _version_ | 1782400911679684608 |
|---|---|
| author | Dennis, Lucas Fling, Steven P Beechem, Joseph M Danaher, Patrick D'Amico, Leonard Disis, Mary Elliott, Nathan Geller, Melissa Jacquemont, Celine Kussick, Steven Shine, Richard Odunsi, Kunle |
| author_facet | Dennis, Lucas Fling, Steven P Beechem, Joseph M Danaher, Patrick D'Amico, Leonard Disis, Mary Elliott, Nathan Geller, Melissa Jacquemont, Celine Kussick, Steven Shine, Richard Odunsi, Kunle |
| author_sort | Dennis, Lucas |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-4646049 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2015 |
| publisher | BioMed Central |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-46460492015-11-20 Preliminary validation of nCounter PanCancer immune profiling of FFPE slides and pbmc in CITN-05, a CITN study of the immunological effects of an IDO1 inhibitor in patients with ovarian carcinoma Dennis, Lucas Fling, Steven P Beechem, Joseph M Danaher, Patrick D'Amico, Leonard Disis, Mary Elliott, Nathan Geller, Melissa Jacquemont, Celine Kussick, Steven Shine, Richard Odunsi, Kunle J Immunother Cancer Poster Presentation BioMed Central 2015-11-04 /pmc/articles/PMC4646049/ http://dx.doi.org/10.1186/2051-1426-3-S2-P84 Text en Copyright © 2015 Dennis et al. http://creativecommons.org/licenses/by/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
| spellingShingle | Poster Presentation Dennis, Lucas Fling, Steven P Beechem, Joseph M Danaher, Patrick D'Amico, Leonard Disis, Mary Elliott, Nathan Geller, Melissa Jacquemont, Celine Kussick, Steven Shine, Richard Odunsi, Kunle Preliminary validation of nCounter PanCancer immune profiling of FFPE slides and pbmc in CITN-05, a CITN study of the immunological effects of an IDO1 inhibitor in patients with ovarian carcinoma |
| title | Preliminary validation of nCounter PanCancer immune profiling of FFPE slides and pbmc in CITN-05, a CITN study of the immunological effects of an IDO1 inhibitor in patients with ovarian carcinoma |
| title_full | Preliminary validation of nCounter PanCancer immune profiling of FFPE slides and pbmc in CITN-05, a CITN study of the immunological effects of an IDO1 inhibitor in patients with ovarian carcinoma |
| title_fullStr | Preliminary validation of nCounter PanCancer immune profiling of FFPE slides and pbmc in CITN-05, a CITN study of the immunological effects of an IDO1 inhibitor in patients with ovarian carcinoma |
| title_full_unstemmed | Preliminary validation of nCounter PanCancer immune profiling of FFPE slides and pbmc in CITN-05, a CITN study of the immunological effects of an IDO1 inhibitor in patients with ovarian carcinoma |
| title_short | Preliminary validation of nCounter PanCancer immune profiling of FFPE slides and pbmc in CITN-05, a CITN study of the immunological effects of an IDO1 inhibitor in patients with ovarian carcinoma |
| title_sort | preliminary validation of ncounter pancancer immune profiling of ffpe slides and pbmc in citn-05, a citn study of the immunological effects of an ido1 inhibitor in patients with ovarian carcinoma |
| topic | Poster Presentation |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4646049/ http://dx.doi.org/10.1186/2051-1426-3-S2-P84 |
| work_keys_str_mv | AT dennislucas preliminaryvalidationofncounterpancancerimmuneprofilingofffpeslidesandpbmcincitn05acitnstudyoftheimmunologicaleffectsofanido1inhibitorinpatientswithovariancarcinoma AT flingstevenp preliminaryvalidationofncounterpancancerimmuneprofilingofffpeslidesandpbmcincitn05acitnstudyoftheimmunologicaleffectsofanido1inhibitorinpatientswithovariancarcinoma AT beechemjosephm preliminaryvalidationofncounterpancancerimmuneprofilingofffpeslidesandpbmcincitn05acitnstudyoftheimmunologicaleffectsofanido1inhibitorinpatientswithovariancarcinoma AT danaherpatrick preliminaryvalidationofncounterpancancerimmuneprofilingofffpeslidesandpbmcincitn05acitnstudyoftheimmunologicaleffectsofanido1inhibitorinpatientswithovariancarcinoma AT damicoleonard preliminaryvalidationofncounterpancancerimmuneprofilingofffpeslidesandpbmcincitn05acitnstudyoftheimmunologicaleffectsofanido1inhibitorinpatientswithovariancarcinoma AT disismary preliminaryvalidationofncounterpancancerimmuneprofilingofffpeslidesandpbmcincitn05acitnstudyoftheimmunologicaleffectsofanido1inhibitorinpatientswithovariancarcinoma AT elliottnathan preliminaryvalidationofncounterpancancerimmuneprofilingofffpeslidesandpbmcincitn05acitnstudyoftheimmunologicaleffectsofanido1inhibitorinpatientswithovariancarcinoma AT gellermelissa preliminaryvalidationofncounterpancancerimmuneprofilingofffpeslidesandpbmcincitn05acitnstudyoftheimmunologicaleffectsofanido1inhibitorinpatientswithovariancarcinoma AT jacquemontceline preliminaryvalidationofncounterpancancerimmuneprofilingofffpeslidesandpbmcincitn05acitnstudyoftheimmunologicaleffectsofanido1inhibitorinpatientswithovariancarcinoma AT kussicksteven preliminaryvalidationofncounterpancancerimmuneprofilingofffpeslidesandpbmcincitn05acitnstudyoftheimmunologicaleffectsofanido1inhibitorinpatientswithovariancarcinoma AT shinerichard preliminaryvalidationofncounterpancancerimmuneprofilingofffpeslidesandpbmcincitn05acitnstudyoftheimmunologicaleffectsofanido1inhibitorinpatientswithovariancarcinoma AT odunsikunle preliminaryvalidationofncounterpancancerimmuneprofilingofffpeslidesandpbmcincitn05acitnstudyoftheimmunologicaleffectsofanido1inhibitorinpatientswithovariancarcinoma |